Internal Medicine Alert - July 30, 2011

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/11. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor,
West Virginia University School of Medicine
Charleston, WV

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine,
UCLA School of Medicine

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Authors
David J. Pierson, MD
Professor, Pulmonary and Critical Care Medicine
Harborview Medical Center
University of Washington, Seattle

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • Does Being Obese Matter If You Have Medicare?
  • Impact of Drug Class on Long-Term Adherence to Antihypertensives
  • Sleep Apnea and Perioperative Complications After Noncardiac Surgery
  • Linagliptin Tablets (Tradjenta™)
  • Clinical Briefs

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Amylin, Boehringer Ingelheim, Novo Nordisk, Teva, and Lilly; he serves on the speakers bureau of Boehringer Ingelheim, Novo Nordisk, and Teva. Associate editors Rahul Gupta, MD, MPH, FACP, author David J. Pierson, MD, Louis Kuritzky, MD, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Associate editor Harold L. Karpman, MD, FACC, FACP serves on the speakers bureau for Forest Laboratories.

Copyright 2011 AHC Media LLC. All rights reserved.